SEC 13F Intelligence

Maxele Advisors, LLC / ABT

Maxele Advisors, LLC’s Abbott Laboratories Position

Does Maxele Advisors, LLC own Abbott Laboratories (ABT)? Yes11.4K shares worth $1M (+1.16% of its 13F portfolio) as of Q4 2025, up from 10.7K shares the prior filed quarter.

Position Value
$1M
Q4 2025
Shares
11.4K
% of Portfolio
+1.16%
Quarters Held
2
currently held

Position History ABT

Reported value by quarter
Q3 ’25: $1MQ3 ’25Q4 ’25: $1MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202511.4K$1M+1.16%
Q3 202510.7K$1M+1.24%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Maxele Advisors, LLC’s full portfolio or all institutional holders of ABT.